Concepedia

Toshiyuki Yamada

TY

Statistics

Publications

81

Citations

4.5K

H-Index

33

Active since

1966

Affiliations

Sasaki Institute(Current)

Kyoto University

Hirosaki University

Nagasaki Institute of Applied Science

Jichi Medical University

Toshiyuki Yamada is an author at Sasaki Institute specializing in life sciences, molecular biology, and medicine.

ORCID

Publications per year

1966–2022

81

Publications

81

Angiotensin II type 2 receptor mediates programmed cell death.

Toshiyuki Yamada, Masato Horiuchi, Victor J. Dzau · Proceedings of the National Academy of Sciences · 1996 · 697 citations

, , +17

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

Akira Matsumori, Toshiyuki Yamada, Hiroshi Suzuki et al. · Heart · 1994 · 520 citations · Full text

, , +15

β2-microglobulin: A new form of amyloid protein associated with chronic hemodialysis

Fumitake Gejyo, Shoji Odani, Toshiyuki Yamada et al. · Kidney International · 1986 · 267 citations · Full text

, , +16

Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.

Toshiyuki Yamada, Akira Matsumori, S Sasayama · Circulation · 1994 · 167 citations · Full text

, , +16

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.

Akira Matsumori, Tetsuo Shioi, Toshiyuki Yamada et al. · Circulation · 1994 · 156 citations · Full text

, , +13

1–5 of 81